Recent progress in tuberculosis prophylactic vaccine strategies and some thoughts / 中华微生物学和免疫学杂志
Chinese Journal of Microbiology and Immunology
; (12): 406-412, 2023.
Article
em Zh
| WPRIM
| ID: wpr-995304
Biblioteca responsável:
WPRO
ABSTRACT
Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis. At present, the situation of tuberculosis control in China and even the world is severe. Bacillus Calmette-Guerin (BCG) vaccine is the only approved vaccine for tuberculosis, but its protective effect is limited. Hence, it is imperative to develop more effective tuberculosis vaccines. Currently, many new tuberculosis vaccine candidates are in clinical or preclinical trials. In this paper, to provide reference for the development of tuberculosis vaccines in China, the status of the research on vaccine candidates were reviewed and the progress in new tuberculosis vaccine strategies were summarized.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Microbiology and Immunology
Ano de publicação:
2023
Tipo de documento:
Article